Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).
   Google Scholar   
Citation:
J Clin Oncol vol 32 (5s) (suppl; abstr 647)
Meeting Instance:
ASCO 2014
Year:
2014
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                     
Networks:
 
Study
NCCTG-N063D
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: